National Alopecia Areata Foundation
-
Chesterbrook’s Aclaris Therapeutics Enters $31.5 Million Royalty, Milestone Payments Deal
Chesterbrook-based Aclaris Therapeutics has agreed to sell $31.5 million of its future Eli Lilly and Co. royalty and milestone payments to a Canadian pension plan,…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
